pA2 online
© Copyright 2004 The British Pharmacological Society

104P University of Bath
Summer Meeting July 2004

Effects of caffeine on D1 dopamine receptors in rat striatum

B. Nolan, C. Briody and K.M. O’Boyle, Department of Pharmacology, Conway Institute for Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland

Print abstract


Search PubMed for:


Nolan B
Briody C
O’Boyle KM

Caffeine is an adenosine A1 and A2 receptor antagonist with marked psychomotor stimulant effects. Substantial evidence suggests that the motor stimulant effects of caffeine are mediated by antagonistic interactions between specific adenosine and dopamine (DA) receptor subtypes located in the basal ganglia (Ferre et al., 1997). The aims of the present study were to examine the in vivo and in vitro effects of caffeine on DA D1 receptors in rat striatum.

DA D1 receptors in male Wistar rat striatum (150-200g) were labelled with [3H] SCH 23390 and non-specific binding was defined using 1 µM piflutixol. The effect of caffeine on D1 receptor density was determined in saturation experiments using striatal membranes prepared from rats that were sacrificed 14 days after cessation of treatment with caffeine, 5 mg/kg i.p. twice daily for 4 days. The effects of caffeine, DPCPX (A1 antagonist), CPA (A1 agonist) and CGS 21680 (A2 agonist) on the affinity of DA for high (KH) and low (KL) affinity states of the D1 receptor were examined in competition experiments. Binding data were analysed using GraphPad Prism.

Treatment of rats with low doses of caffeine for 4 days caused a 50% reduction in striatal D1 receptor density from 21.6 ±2.3 to 11.3 ±1.4 fmol mg-1 wet wt (mean ±SEM, n=4) (p<0.01, t-test). There was no change in Kd (control: 0.21 ±0.10 nM, caffeine: 0.13 ±0.08 nM). The displacement of [3H] SCH 23390 by DA was best described by a two-site model under control conditions (Table 1). Caffeine, DPCPX and CPA all converted the interaction between DA and D1 receptors into single, low affinity site. In contrast, CGS 21680 did not alter the two-site interaction of DA (Table 1).

Table 1. Effect of adenosine ligands on affinity of DA for rat striatal D 1 receptors

Treatment

Two-site fit

One-site fit

pKi

n

%RH

pKH

pKL

Control

23%

8.7 ±0.05

5.5 ±0.2

-

6

Caffeine, 20 mM

-

-

-

5.8 ±0.1

6

DPCPX, 20 nM

-

-

-

5.6 ±0.2

3

CPA, 20 nM

-

-

-

6.0 ±0.2

6

CGS 21680, 20 nM

25%

10.2 ±1.0

6.2 ±0.2

-

4

mean ±SEM; pKH, pKL and pKi are -log of the corresponding KH, KL and Ki values.

In summary, in vivo administration of low doses of caffeine caused a significant and persistent reduction in the density of D1 receptors. In vitro treatment with caffeine prevented DA having a high affinity interaction with D1 receptors. This latter effect was mimicked by an A1 agonist, an A1 antagonist but not by an A2 agonist.

Ferre S et al., (1997) Trends Neurosci. 20, 482-487

This work was supported by Enterprise Ireland and University College Dublin